These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 9834251)
61. Anti-thymocyte globulin treatment of a patient for paroxysmal nocturnal haemoglobinuria-aplastic anaemia syndrome: complement activation and transient decrease of the PNH clone. Ebenbichler CF; Würzner R; Sandhofer AD; Niederwieser D; Dierich MP; Patsch JR Immunobiology; 1996-1997; 196(5):513-21. PubMed ID: 9145329 [TBL] [Abstract][Full Text] [Related]
62. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Brodsky RA; Mukhina GL; Li S; Nelson KL; Chiurazzi PL; Buckley JT; Borowitz MJ Am J Clin Pathol; 2000 Sep; 114(3):459-66. PubMed ID: 10989647 [TBL] [Abstract][Full Text] [Related]
63. Aurin tricarboxylic acid protects against red blood cell hemolysis in patients with paroxysmal nocturnal hemoglobinemia. Lee M; Narayanan S; McGeer EG; McGeer PL PLoS One; 2014; 9(1):e87316. PubMed ID: 24489894 [TBL] [Abstract][Full Text] [Related]
64. Abnormalities in the expression of CD55 and CD59 surface molecules on peripheral blood cells are not specific to paroxysmal nocturnal hemoglobinuria. Ruiz-Delgado GJ; Vázquez-Garza E; Méndez-Ramírez N; Gómez-Almaguer D Hematology; 2009 Feb; 14(1):33-7. PubMed ID: 19154662 [TBL] [Abstract][Full Text] [Related]
65. A Rare Case of Paroxysmal Nocturnal Hemoglobinuria With Bilateral Renal Vein Thrombosis. Lodhi OUH; Sohail S; Hassan D Cureus; 2020 Jun; 12(6):e8806. PubMed ID: 32724752 [TBL] [Abstract][Full Text] [Related]
66. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Brodsky RA; Mukhina GL; Nelson KL; Lawrence TS; Jones RJ; Buckley JT Blood; 1999 Mar; 93(5):1749-56. PubMed ID: 10029605 [TBL] [Abstract][Full Text] [Related]
67. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis. Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964 [TBL] [Abstract][Full Text] [Related]
68. Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay. van der Schoot CE; Huizinga TW; van 't Veer-Korthof ET; Wijmans R; Pinkster J; von dem Borne AE Blood; 1990 Nov; 76(9):1853-9. PubMed ID: 2145990 [TBL] [Abstract][Full Text] [Related]
69. [Immunophenotyping study on the blood cells of the patients with paroxysmal nocturnal hemoglobinuria]. Chen G; Shao Z; Jia H; Chu Y; Shen D; Zhang Y; Zhang J Zhonghua Xue Ye Xue Za Zhi; 1997 Apr; 18(4):190-2. PubMed ID: 15622765 [TBL] [Abstract][Full Text] [Related]
70. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins. Edberg JC; Salmon JE; Whitlow M; Kimberly RP J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101 [TBL] [Abstract][Full Text] [Related]
71. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. Wilcox LA; Ezzell JL; Bernshaw NJ; Parker CJ Blood; 1991 Aug; 78(3):820-9. PubMed ID: 1713516 [TBL] [Abstract][Full Text] [Related]
72. [Studies on the expression of complement regulatory proteins in three kinds of stem cell defect anemias and its clinical implications]. Xu C; Zhang T; Zhao R Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):511-4. PubMed ID: 11721394 [TBL] [Abstract][Full Text] [Related]
73. Paroxysmal nocturnal hemoglobinuria from bench to bedside. Pu JJ; Brodsky RA Clin Transl Sci; 2011 Jun; 4(3):219-24. PubMed ID: 21707954 [TBL] [Abstract][Full Text] [Related]
74. Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia. Meletis J; Terpos E; Samarkos M; Meletis C; Apostolidou E; Komninaka V; Anargyrou K; Korovesis K; Mavrogianni D; Variami E; Viniou N; Konstantopoulos K Hematology; 2002 Apr; 7(2):69-74. PubMed ID: 12186694 [TBL] [Abstract][Full Text] [Related]
75. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines. Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796 [TBL] [Abstract][Full Text] [Related]
76. Altered Expression Levels of CD59, but Not CD55, on Red Blood Cells in Stored Blood. Al-Faris L; Al-Humood S Med Princ Pract; 2019; 28(4):361-366. PubMed ID: 30844815 [TBL] [Abstract][Full Text] [Related]
77. Persistence of affected T lymphocytes in long-term clinical remission in paroxysmal nocturnal hemoglobinuria. Nakakuma H; Nagakura S; Kawaguchi T; Iwamoto N; Hidaka M; Horikawa K; Kagimoto T; Tsuruzaki R; Takatsuki K Blood; 1994 Dec; 84(11):3925-8. PubMed ID: 7524752 [TBL] [Abstract][Full Text] [Related]
78. Flow cytometric measurement of glycosylphosphatidyl-inositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal hemoglobinuria. Kwong YL; Lee CP; Chan TK; Chan LC Am J Clin Pathol; 1994 Jul; 102(1):30-5. PubMed ID: 8037165 [TBL] [Abstract][Full Text] [Related]